Sipatrigine

CAS : 130800-90-7

Ref. 3D-FFA80090

Informations sur le produit

• Nom: Sipatrigine
• Synonymes: 2-(4-Methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinamine, 2-(4-Methyl-piperazin-1-yl)-5-(2,3,5-trichloro-phenyl)-pyrimidin-4-ylamine, 2-(4-Methylpiperazin-1-Yl)-5-(2,3,5-Trichlorophenyl)-Pyrimidin-4-Amine, 4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-, 619C89, Bw 619C89, L-Glutamic Acid, N-[4-[2-(2-Amino-4,7-Dihydro-4-8 Oxo-1H-Pyrrolo[2,3-D] Pyrimidin-5-Yl)Ethyl]Benzoyl]-, Disodium Salt, Heptahydrate, disodium (2S)-2-[({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)amino]pentanedioate

Description

Sipatrigine is a drug that belongs to the group of pharmacological agents. It has been shown to have neuroprotective and anti-epileptic effects in animal models. Sipatrigine inhibits voltage-gated potassium channels, slowing the influx of calcium ions into nerve cells and preventing neuronal cell death. It is also an inhibitor of glutamate release, which may contribute to its therapeutic effects. Sipatrigine has a side-effect profile similar to lamotrigine, with the exception of being less sedating.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 372.68 g/mol
• Formule: C₁₅H₁₆Cl₃N₅
• Degré de pureté: Min. 95%